Alpha Teknova, Inc. (TKNO): Company Short-Term Debts

Public company logo of Teknova Inc (TKNO)

The confirmed price history on the chart reflects that Alpha Teknova, Inc. (TKNO) short-term liabilities are fixed at 0.00. The business specializes in creating high-tech diagnostic and therapeutic devices. Management is betting on expanding production lines and maintaining flawless product quality control. Alpha Teknova, Inc. (TKNO) is developing its own capacities, eschewing mergers and entering into long-term personalized supply agreements for gene medicine developers.

TKNO (Teknova) Company Short-Term Debts history from 07/04/2022 to 10/30/2026

Analytical breakdowns for Teknova Inc (TKNO)

- stock price and consensus target price:
Stock Price Teknova|TKNO - Analyst Median Target
- stock exchange capitalization data:
Market Capitalization Alpha Teknova|TKNO - Real Price to Acquire Entire Company
- business book valuation details:
Book Value per Share Teknova|TKNO - Book Capitalization|Market Value to Book Value Ratio teknova.com|TKNO - Aggregate Company Assets
- debt and liquidity data:
Total Debt to Equity Ratio Alpha Teknova, Inc.|TKNO - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Alpha Teknova, Inc.|TKNO - Company Total Debt Obligations|Debt to Book Capitalization Ratio Alpha Teknova|TKNO - Company Long-Term Indebtedness|Company Short-Term Debt Teknova|Quick Liquidity Indicator teknova.com
- net income and valuation multiples indicators:
TKNO - Profit After Payment of Taxes
Fundamental company analysis:TKNO - Teknova
Flagship merchandise of Teknova Inc

The stability of Alpha Teknova, Inc. (TKNO) depends on the demand for biochemical reagents and client investments in R&D. Monitoring current debt allows for tracking the dynamics of obligations due within one year. This metric aggregates short-term loans and promissory notes, revealing the pressure on liquidity. An increase in this indicator signals either an expansion of resources or a risk of capital deficiency. Controlling this amount is critical for maintaining the stability of the financing structure.

Direct competitors

Intuitive - Company Short-Term Debts|Short-Term Debt Volume Danaher Corporation DHR|BDX: Company Short-Term Debts|Company Current Liabilities STERIS Group|WST (West Pharmaceutical Services) - Company Short-Term Debts|Company Short-Term Debts baxter.com|Company Short-Term Debt Masimo (MASI)|Company Short-Term Debt STVN (Stevanato Group SpA)|Teleflex Inc - Company Current Liabilities|Company Short-Term Loans and Borrowings MMSI|Envista Holdings - Company Short-Term Debts|Short-Term Debt Volume icumed.com ICUI|Dentsply Sirona (XRAY) - Company Short-Term Debt|Company Short-Term Indebtedness LMAT|Company Short-Term Debt AtriCure Corp|STAAR Surgical Co (STAA) - Short-Term Debt Volume|Company Current Liabilities NAGE (ChromaDex)|Amount of Current Liabilities ZIMV|Company Short-Term Debt AngioDynamics ANGO|Company Short-Term Loans and Borrowings CERS|MGRM: Company Current Liabilities|STSS - Company Short-Term Debts|infusystem.com (INFU) - Company Short-Term Debt|Company Current Liabilities utahmed.com|KRMD (KORU Medical Systems, Inc.) - Company Short-Term Debts|Short-Term Debt Nyxoah SA NYXH|Company Short-Term Debt Microbot Medical Inc (MBOT)|Pro-Dex Inc. - Company Short-Term Indebtedness|Zentek Ltd. - Company Current Liabilities|Amount of Current Liabilities ELUT (elutia.com)|MLSS - Company Short-Term Debt|Short-Term Debt Volume NEXGEL Inc. NXGL|RVP: Company Short-Term Debts|Harvard Bioscience Inc. (HBIO) - Company Short-Term Debts|Company Short-Term Debt Femasys Inc.|Company Short-Term Debt MHUA|Company Short-Term Debt Predictive Oncology (POAI)|CJMB: Current Liabilities|Company Short-Term Debts ATRI (Atrion Corp)|Company Short-Term Loans and Borrowings NURO